MOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new ...
MOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced two new analyses from FISH&CHIPS, a real-world ...
MOUNTAIN VIEW, Calif., Oct. 18, 2024 (GLOBE NEWSWIRE) -- HeartFlow, Inc., the global leader in non-invasive artificial intelligence (AI) heart care solutions, today announced that the American Medical ...
MOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and ...
HeartFlow's market-moving announcement was that the U.S. Food and Drug Administration (FDA) granted approval for its HeartFlow Plaque Analysis algorithm. Following that, the company said the product ...
HeartFlow (NASDAQ: HTFL) had a Thursday to remember, at least as far as its stock was concerned. The specialty healthcare company saw its share price leap by 9% that day, on news that its technology ...
Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England’s National Health Service ...
Hosted on MSN
Why HeartFlow Stock Rocketed 14% Higher Today
The cardiac health specialist announced FDA approval for one of its diagnostic products. It didn't hesitate to say the HeartFlow Plaque Analysis is now available for purchase. 10 stocks we like better ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results